SILDENAFIL
- Product NDC
- 69097-951
- 11-digit product format
- 690970951
- Labeler code
- 69097
- Product ID
- 69097-951_31499b53-d7e9-49e4-8eaa-c527c7403f9c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SILDENAFIL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- CIPLA USA INC.,
- Application
- ANDA207178
- Marketing category
- ANDA
- Marketing start
- 2020-07-10
- Substance
- SILDENAFIL CITRATE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SILDENAFIL
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SILDENAFIL CITRATE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | BW9B0ZE037 |
| Rxcui | 312950, 314228, 314229 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69097-951-02 | SILDENAFIL | 30 in 1 BOTTLE | TABLET | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-951 | SILDENAFIL TABLET [CIPLA USA INC.,] | 3 | Current NDC, Legacy NDC, 1 package rows | 20230504_15372a7c-2935-48dc-a55a-8966719b50be.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-951-02 | 69097095102 | 30 TABLET in 1 BOTTLE (69097-951-02) | 30 tablet | 2020-07-10 | 0000-00-00 | No | No | Current |